<?xml version="1.0" encoding="UTF-8"?>

<rootTag>
  <Award>
    <AwardTitle>PFI-AIR:Industry-Academia Research Partnership for Developing &amp; Implementing Non-Destructive Characterization and Assessment of Pharmaceutical Oral Dosages in Continuous Manufac</AwardTitle>
    <AwardEffectiveDate>07/01/2012</AwardEffectiveDate>
    <AwardExpirationDate>04/30/2015</AwardExpirationDate>
    <AwardAmount>956962</AwardAmount>
    <AwardInstrument>
      <Value>Standard Grant</Value>
    </AwardInstrument>
    <Organization>
      <Code>07070000</Code>
      <Directorate>
        <LongName>Directorate For Engineering</LongName>
      </Directorate>
      <Division>
        <LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
      </Division>
    </Organization>
    <ProgramOfficer>
      <SignBlockName>Barbara H. Kenny</SignBlockName>
    </ProgramOfficer>
    <AbstractNarration>This NSF Accelerating Innovation Research (AIR) project will establish a public-private ecosystem for the development and implementation of innovative strategies for non-destructive characterization and assessment of pharmaceutical oral dosage forms targeted to continuous manufacturing processes. Non-destructive testing also impacts the quality of health-care treatment, circumventing the issues posed by destructive testing, in which dosages given to patients can never be tested. Non-destructive testing additionally can provide a foundation to better understand critical scientific issues such as within-patient and patient-to-patient response variability since the variability associated with the manufacturing process can be de-convoluted by this approach. &lt;br/&gt;&lt;br/&gt;Enabling non-destructive testing has significant economic impact on the quality and control of therapeutics. From an economic perspective, non-destructive testing can provide a pathway for advancing Real-Time Release Testing (RTRT), which has the potential to reduce manufacturing costs associated with large captive waiting-for-release inventories and failed batches. Moreover, non-destructive testing can provide a competitive edge for high-quality U.S.-based manufacturing by retaining and expanding U.S. manufacturing jobs in the pharmaceutical sector.</AbstractNarration>
    <MinAmdLetterDate>07/01/2012</MinAmdLetterDate>
    <MaxAmdLetterDate>09/30/2013</MaxAmdLetterDate>
    <ARRAAmount/>
    <AwardID>1237873</AwardID>
    <Investigator>
      <FirstName>Fernando</FirstName>
      <LastName>Muzzio</LastName>
      <EmailAddress>fjmuzzio@yahoo.com</EmailAddress>
      <StartDate>09/30/2013</StartDate>
      <EndDate/>
      <RoleCode>Co-Principal Investigator</RoleCode>
    </Investigator>
    <Investigator>
      <FirstName>Alberto</FirstName>
      <LastName>Cuitino</LastName>
      <EmailAddress>cuitino@jove.rutgers.edu</EmailAddress>
      <StartDate>07/01/2012</StartDate>
      <EndDate/>
      <RoleCode>Principal Investigator</RoleCode>
    </Investigator>
    <Investigator>
      <FirstName>Mauricio</FirstName>
      <LastName>Futran</LastName>
      <EmailAddress>mauricio.futran@rutgers.edu</EmailAddress>
      <StartDate>07/01/2012</StartDate>
      <EndDate/>
      <RoleCode>Co-Principal Investigator</RoleCode>
    </Investigator>
    <Institution>
      <Name>Rutgers University New Brunswick</Name>
      <CityName>Piscataway</CityName>
      <ZipCode>088543925</ZipCode>
      <PhoneNumber>8489320150</PhoneNumber>
      <StreetAddress>33 Knightsbridge Road</StreetAddress>
      <CountryName>United States</CountryName>
      <StateName>New Jersey</StateName>
      <StateCode>NJ</StateCode>
    </Institution>
    <ProgramElement>
      <Code>8019</Code>
      <Text>Accelerating Innovation Rsrch</Text>
    </ProgramElement>
    <ProgramReference>
      <Code>1662</Code>
      <Text>PARTNRSHIPS FOR INNOVATION-PFI</Text>
    </ProgramReference>
    <ProgramReference>
      <Code>8019</Code>
      <Text>Accelerating Innovation Rsrch</Text>
    </ProgramReference>
  </Award>
</rootTag>
